# Diffusion MRI in Heart Failure

> **NCT02973633** · EARLY_PHASE1 · RECRUITING · sponsor: **Massachusetts General Hospital** · enrollment: 160 (estimated)

## Conditions studied

- Heart Failure
- Myocardial Infarction
- Left Ventricular Hypertrophy

## Interventions

- **DEVICE:** Diffusion Tensor MRI (DTI)
- **DRUG:** Gadolinium DOTA Meglumine

## Key facts

- **NCT ID:** NCT02973633
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2017-06-30
- **Primary completion:** 2027-12-31
- **Final completion:** 2028-12-31
- **Target enrollment:** 160 (ESTIMATED)
- **Last updated:** 2025-12-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02973633

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02973633, "Diffusion MRI in Heart Failure". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02973633. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*